Venetoclax-based salvage therapy for adult patients with relapsed/refractory acute lymphoblastic leukemia.

Published in: European journal of haematology (2023)

Our data demonstrated the possible efficacy of ven-chemotherapy and ven-navitoclax in r/r ALL with moderate toxicity.

Keyphrases